DEVELOPMENT PARTNER ARRANGEMENTS	12 Months Ended
Dec. 31, 2025
Collaborative Arrangements And Noncollaborative Arrangement Transaction [Abstract]
DEVELOPMENT PARTNER ARRANGEMENTS	NOTE 8 – DEVELOPMENT PARTNER ARRANGEMENTS License Agreements On October 16, 2015, Legacy PCT entered into a patent license agreement with P&G (the “Original Patent License Agreement”). This agreement was subsequently replaced by an Amended and Restated Patent License Agreement dated July 28, 2020, and further modified by a Side Letter Agreement dated February 12, 2021 (collectively, the “License Agreement”). The License Agreement outlines three phases, with specific deliverables for each phase. During Phase 1 of the agreement, P&G provides up to one full-time employee to assist in the execution of Legacy PCT’s research and development activities, and Phase 2 increases this to two full-time employees. Phase 3 covers the commercial manufacturing phase of the licensed product, including construction of the first commercial facility, production capacity targets, and pricing terms with P&G and third parties. In April 2019, Legacy PCT elected to enter into Phase 3 of the agreement and prepaid a royalty payment in the amount of $2.0 million, which will be reduced against future royalties payable, as sales occur. Where the Company has made royalty payments to its product development partners, the Company expenses such payments as incurred unless it has determined that it is probable that such prepaid royalties have future economic benefit. In such cases, prepaid royalties will be reduced as the royalties would have been due to the partners. As of December 31, 2025 and 2024, $2.0 million is recorded in each period for the royalties in prepaid expenses and other current assets in the Consolidated Balance Sheets. On November 13, 2019, Legacy PCT entered into a patent sublicense agreement with Impact Recycling Limited through the term of the patents. The agreement outlines an initial license fee of $2.5 million and royalties on production using the license. The initial license fee of $2.5 million is recorded in prepaid expenses and other noncurrent assets in the Consolidated Balance Sheets. In May 2021, the Company began using the technology covered by the agreement and commenced straight-line amortization of the fee, which will be fully amortized on May 31, 2036. Effective February 21, 2025, PCT LLC and P&G executed an amendment to the License Agreement, which, among other terms, permanently waives the exclusivity license clawback provisions for facilities located in North America and extends the exclusivity provisions for facilities outside North America. Block and Release Agreement On June 23, 2020, Legacy PCT entered into a block and release agreement with Total Petrochemicals & Refining S.A./N.V. (“Total”). Upon execution of the agreement, Total made a prepayment of $5.0 million for future receipt of resin consisting of recycled polypropylene. The $5.0 million prepayment is recorded as deferred revenue in the Consolidated Balance Sheets. The deferred revenue remains noncurrent provided the Company complies with certain provisions contained in the agreement.

DEVELOPMENT PARTNER ARRANGEMENTS

12 Months Ended

Dec. 31, 2025

Collaborative Arrangements And Noncollaborative Arrangement Transaction [Abstract]

NOTE 8 – DEVELOPMENT PARTNER ARRANGEMENTS

License Agreements

On October 16, 2015, Legacy PCT entered into a patent license agreement with P&G (the “Original Patent License Agreement”). This agreement was subsequently replaced by an Amended and Restated Patent License Agreement dated July 28, 2020, and further modified by a Side Letter Agreement dated February 12, 2021 (collectively, the “License Agreement”).

The License Agreement outlines three phases, with specific deliverables for each phase. During Phase 1 of the agreement, P&G provides up to one full-time employee to assist in the execution of Legacy PCT’s research and development activities, and Phase 2 increases this to two full-time employees. Phase 3 covers the commercial manufacturing phase of the licensed product, including construction of the first commercial facility, production capacity targets, and pricing terms with P&G and third parties. In April 2019, Legacy PCT elected to enter into Phase 3 of the agreement and prepaid a royalty payment in the amount of $2.0 million, which will be reduced against future royalties payable, as sales occur. Where the Company has made royalty payments to its product development partners, the Company expenses such payments as incurred unless it has determined that it is probable that such prepaid royalties have future economic benefit. In such cases, prepaid royalties will be reduced as the royalties would have been due to the partners. As of December 31, 2025 and 2024, $2.0 million is recorded in each period for the royalties in prepaid expenses and other current assets in the Consolidated Balance Sheets.

On November 13, 2019, Legacy PCT entered into a patent sublicense agreement with Impact Recycling Limited through the term of the patents. The agreement outlines an initial license fee of $2.5 million and royalties on production using the license. The initial license fee of $2.5 million is recorded in prepaid expenses and other noncurrent assets in the Consolidated Balance Sheets. In May 2021, the Company began using the technology covered by the agreement and commenced straight-line amortization of the fee, which will be fully amortized on May 31, 2036.

Effective February 21, 2025, PCT LLC and P&G executed an amendment to the License Agreement, which, among other terms, permanently waives the exclusivity license clawback provisions for facilities located in North America and extends the exclusivity provisions for facilities outside North America.

Block and Release Agreement

On June 23, 2020, Legacy PCT entered into a block and release agreement with Total Petrochemicals & Refining S.A./N.V. (“Total”). Upon execution of the agreement, Total made a prepayment of $5.0 million for future receipt of resin consisting of recycled polypropylene. The $5.0 million prepayment is recorded as deferred revenue in the Consolidated Balance Sheets. The deferred revenue remains noncurrent provided the Company complies with certain provisions contained in the agreement.